Skip to content

Supreme LMA and Endotracheal Intubation Use in Caesarean Section

Supreme LMA Versus Endotracheal Intubation in General Anaesthesia for Elective Caesarean Section- a Randomised Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01858467
Enrollment
920
Registered
2013-05-21
Start date
2013-05-31
Completion date
2014-07-31
Last updated
2018-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Complications; Cesarean Section

Keywords

Airway, Cesarean

Brief summary

The LMA Supreme (SLMA) is a single-use supraglottic device that provides a good seal for positive pressure ventilation and good first attempt insertion rate of 98% in low-risk patients undergoing Caesarean section. It has a double aperture design that facilitates the introduction of an orogastric tube to aspirate gastric contents. The current practice is to use endotracheal intubation with rapid sequence induction in general anaesthesia for Caesarean section. The primary study hypothesis is the first attempt insertion success rate of SLMA and endotracheal intubation are equivalent with a difference of less than 3%.

Detailed description

We propose a randomised controlled trial to study the first attempt insertion success rate of supreme LMA versus endotracheal intubation in general anaesthesia for elective Caesarean section.

Interventions

DEVICEEndotracheal intubation

Portex endotracheal tube 6.5mm or 7.0mm internal diameter

Supreme Laryngeal Mask Airway Size 3 or Size 4 with gastric tube insertion.

Sponsors

KK Women's and Children's Hospital
CollaboratorOTHER_GOV
Wei Yu Yao
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Age 18 to 50 years old * ASA 1 or 2 * Fasted at least 6 hours * Weight 40 to 75kg * Normal airway assessment * Singleton term pregnancy (\>36weeks) * Elective Caesarean section

Exclusion criteria

* In labour * Body mass index \>35 * Difficult airway (Mallampati 4 or abnormal airway assessment) * Gastrooesophageal reflux disease

Design outcomes

Primary

MeasureTime frameDescription
First attempt insertion success rate1 hourAn attempt is defined as insertion and complete withdrawal of the device from the patient's airway

Secondary

MeasureTime frameDescription
Aspiration1 hourSigns of aspiration as evidenced by perioperative hypoxemia, wheezing or crepitations upon auscultation of lungs or postoperative dyspnea with chest x ray signs of aspiration
blood on SLMA on removal1 hourinspection for presence of blood on Supreme Laryngeal Mask Airway on removal
Sore Throat1 hourSore throat present in the postanaesthesia care unit
Patient satisfaction1 hourPatient satisfaction with whole anaesthetic experience at 24 hours postsurgery (0 to 100%)
Time to effective airway placement1 hourInterval from when the device was picked up until appearance of the first end-tidal carbon dioxide wave form
Seal pressure1 hourRecorded by closing the adjustable pressure limiting valve and insufflating the closed breathing system with 3L/min fresh gas flow. The peak circuit airway pressure achieved was recorded.
Gastric aspirate1 hourVolume of gastric aspiration using gastric tube and pH of gastric aspirate using litmus paper
Neonatal outcomes1 hourNeonatal birthweight. APGAR score. Umbilical venous cord pH.
Regurgitation1 hourGastric contents identified in the mouth with pH less than 4

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026